By Dialogo December 17, 2014 “The goal is to restore security conditions and reestablish the rule of law and peace in all the towns of this region,” Rubido told reporters. The Soldiers and PF agents will provide security to residents in areas which have seen an increase in violence as a result of battles between drug cartels and gangs. There, organized crime groups are fighting for control of lucrative drug smuggling routes. Colombia’s National Navy, Panama’s National Aeronaval Service (SENAN) and US Military troops partnered to seize 295 kilograms of cocaine and 288 kilograms of marijuana from a vessel in the Caribbean Sea on December 7. Mexican troops and Federal Police bolster security in Acapulco The Armed Forces of the three countries cooperated closely to make the seizures and arrests. Colombia’s Navy obtained intelligence about the suspicious vessel and alerted U.S. Armed Forces, which forwarded the information to SENAN. Colombia, Panama, and the United States have signed international cooperation agreements that allow them to exchange information to carry out interdictions of suspicious vessels. The goal of the federal government is to “establish permanent security conditions” so residents will “have the certainty that they will have the necessary guarantees to enjoy their time off” during the holiday season, according to Rubido. Colombia, Panama, and the United States have signed international cooperation agreements that allow them to exchange information to carry out interdictions of suspicious vessels. The Soldiers and PF agents will provide security to residents in areas which have seen an increase in violence as a result of battles between drug cartels and gangs. There, organized crime groups are fighting for control of lucrative drug smuggling routes. The goal of the federal government is to “establish permanent security conditions” so residents will “have the certainty that they will have the necessary guarantees to enjoy their time off” during the holiday season, according to Rubido. They also arrested two suspects, but military authorities did not immediately disclose their names. The drugs were bound for Central America, military officials suspect. Mexican Army troops and Federal Police (PF) assumed command of public safety last week in the Pacific Coast resort city of Acapulco, according National Security Commissioner Monte Alejandro Rubido. The Armed Forces of the three countries cooperated closely to make the seizures and arrests. Colombia’s Navy obtained intelligence about the suspicious vessel and alerted U.S. Armed Forces, which forwarded the information to SENAN. They also arrested two suspects, but military authorities did not immediately disclose their names. The drugs were bound for Central America, military officials suspect. President Enrique Peña Nieto’s administration has bolstered security in 36 towns in the Hot Land, a region known for drug trafficking activity that encompasses parts of the states of Guerrero, Michoacán, Morelos and Mexico, Rubido said, adding the forces will be under the Defense Ministry’s command. Mexican Army troops and Federal Police (PF) assumed command of public safety last week in the Pacific Coast resort city of Acapulco, according National Security Commissioner Monte Alejandro Rubido. Colombia’s National Navy, Panama’s National Aeronaval Service (SENAN) and US Military troops partnered to seize 295 kilograms of cocaine and 288 kilograms of marijuana from a vessel in the Caribbean Sea on December 7. President Enrique Peña Nieto’s administration has bolstered security in 36 towns in the Hot Land, a region known for drug trafficking activity that encompasses parts of the states of Guerrero, Michoacán, Morelos and Mexico, Rubido said, adding the forces will be under the Defense Ministry’s command. Mexican troops and Federal Police bolster security in Acapulco “The goal is to restore security conditions and reestablish the rule of law and peace in all the towns of this region,” Rubido told reporters.
Committee Chairman Davis also defended the FDA. In a statement prepared for the hearing, he said the contamination problems this year were not foreshadowed by those found in the 2003 inspection. He also asserted that the FDA’s response to the contamination reported in August was hindered by Chiron’s delay in reporting on its own investigation of the problem. Davis also said the reason the FDA had no advance knowledge of British authorities’ decision to close the plant was that British law bars agencies from sharing commercial information with other governments without the consent of the involved buiness. Crawford promised that the FDA will carefully analyze Chiron’s plans to correct the Liverpool plant’s problems and will thoroughly inspect the plant after corrective actions are taken, probably in February or March of 2005. “If FDA had acted differently—by issuing an official warning letter, re-inspecting the facility, and responding aggressively to the August 2004 contamination—the flu vaccine shortage might have been avoided or mitigated,” Waxman said in a 13-page memo. The shortage was triggered by the loss of up to 48 million doses of vaccine that Chiron was expected to supply. The FDA found serious and widespread problems at the Liverpool plant (then owned by Powderject Corp. and later bought by Chiron) in June 2003. Problems included defects in 20 areas of vaccine manufacture and high levels of bacterial contamination in several lots of vaccine after a filtration step that was supposed to remove most bacteria. Davis also expressed optimism that Chiron will be able to make flu vaccine next year. He said the MHRA is “extremely pleased” with Chiron’s remediation plan and will inspect the plant in late December to assess the company’s progress. The FDA didn’t send its final report on the June 2003 inspection to Chiron until June 2004, 9 months after it should have been sent. Manufacture of the 2004 vaccine supply was well under way by then. Davis said that after vaccine contamination was found in August, Chiron told the FDA it would do an internal investigation and report on it by Oct 4. As it turned out, the company gave its report to the MHRA Sept 24 but did not send it to the FDA until after the MHRA suspended the plant’s license on Oct 5, Davis said. FDA officials told Davis’s staff that if they had received the report sooner, they would have reinspected the plant sooner, Davis reported. Waxman, ranking minority member of the House Committee on Government Reform, distributed his memo at a Nov 17 committee hearing at which Crawford testified. The memo is based on a review of more than 1,000 pages of FDA documents dealing with the agency’s oversight of the Chiron flu vaccine plant. The FDA provided the documents in response to a request from Waxman and the committee chairman, Rep. Tom Davis, R-Va. The committee chairman rejected the charge that the FDA took a passive approach to Chiron after Aug 25. “All documents and meetings confirm that FDA followed routine protocol in responding to Chiron’s initial contact with the FDA and continued to follow protocol with each step the agency took after August 25th,” he stated. After Chiron reported in August that eight lots of vaccine were contaminated, the company told FDA it had found the cause of the contamination and that it was confined to the eight lots, according to Crawford. On Sept 28, a company official assured a Senate committee that Chiron would be able to supply 46 million to 48 million doses, he said. After reviewing FDA documents, Rep. Henry Waxman, D-Calif., said the FDA also failed to respond properly when Chiron reported in August 2004 that several lots of flu vaccine from the Liverpool plant were contaminated. After the 2003 inspection, the agency never inspected the plant again until after British authorities shut it down. Shortly after the 2003 inspection, Chiron officials asked to meet with the FDA to review their response plan, but the FDA ignored the request. The FDA took a “passive” approach after Chiron notified it Aug 25 that millions of doses of vaccine were contaminated. Instead of sending inspectors, the agency relied on weekly conference calls with Chiron to monitor the company’s remedial efforts. FDA officials never asked Chiron or the British government about British regulatory activity. Crawford reported that the FDA had no knowledge of the British Medicine and Healthcare Products Regulatory Agency (MHRA) decision to close the Chiron plant until it was announced Oct 5. The head of the MHRA said the agency had no legal authority to notify the FDA of its decision in advance, Crawford said. After the 2003 inspection, the FDA decided to ask the company to correct the problems voluntarily, even though the inspection team initially had recommended official enforcement action. Crawford, in his prepared statement to the committee, said the FDA first found problems at the Liverpool plant in a 1999 inspection and issued a warning letter at the time. Inspections in 2001 and 2003 showed that conditions were improving but some problems remained, he said. He added that the company’s plans to correct the deficiencies appeared adequate. The key allegations in Waxman’s memo include the following: Nov 23, 2004 (CIDRAP News) – The Food and Drug Administration (FDA) found serious problems at the Chiron Corp. flu vaccine plant in England in 2003 but failed to follow up in time to prevent the loss of half of the US vaccine supply with the plant’s shutdown by British regulators last month, a Democratic congressman charged last week. Acting FDA Commissioner Lester M. Crawford acknowledged in congressional testimony that the FDA did not reinspect the Chiron plant until after British authorities shut it down. But, according to a Nov 17 New York Times report, he said the problems found last year were unrelated to the contamination in this year’s vaccine. “The proof of that is that the 2003 vaccine production was completed on schedule and none of it was condemned,” he was quoted as saying. Davis, in defending the FDA, said in his prepared statement for the hearing, “While some issues at the facility continued from 2003 until September of 2004, Chiron’s license suspension was not based on contamination in flu vaccine lots or other issues addressed in previous inspections. It would be inappropriate to imply that problems at the Chiron facility in 2003 recurred in 2004 and contributed to the closure of the facility.” Chiron, FDA, and MHRA all blame this year’s problems on a systemic “lack of manufacturing oversight and execution,” he stated. The memo says that FDA officials met with the committee staff Nov 15 and acknowledged that some of the problems noted in 2003 were “the same as or relevant to” the problems that occurred this year. But the officials said that the contamination problems this year were worse and more widespread than in 2003 and that an increase in the plant’s output this year contributed significantly to the worsening of conditions. The officials said the FDA decided not to take enforcement action against the plant in 2003 because conditions there seemed to be improving rather than deteriorating. A statement prepared by Davis’s staff labeled Waxman’s memo “extremely misleading” and “another partisan attack” on the Bush administration. The statement says Waxman ignored explanations that the FDA, Chiron, and MHRA provided concerning their documents and actions. Problems revealed in the June 2003 inspection recurred in 2004 and contributed to the closure of the plant. After the British suspended the plant’s license in October, the FDA inspected it again and subsequently cited “bioburden” problems that had not been corrected since the 2003 inspection.
Image source: ums.gov.plThe local authority of the Polish maritime administration in Szczecin has selected Dutch dredging company Van den Herik to design and execute the deepening and widening of the port entrance at Police, Poland.According to the Dutch Water Sector, Van den Herik won this €5.1 million worth tender.The signing of the contract took place during the visit of a Dutch trade mission to Poland (11 October), which was led by Dutch Minister Cora van Nieuwenhuizen of Infrastructure and Water Management.The City of Police is situated downstream of the Oder River, near the Baltic Sea. The sea port comprises of four terminals and is currently the fourth largest seaport in Poland in terms of quantity of goods subject to loading/unloading operations.The dredging work will consist of deepening the approach track on the Police Channel to 10.5m and widening in the bottom up to 100m. Additional the Kiełpiń Canal will be deepened up to 3m and widened up to 25m, and a bend (to a depth of 3.0m and a width of 35m).Under the deal, the contractor will also strengthen the slope of the Kiełpiński Ostrów island.The deadline for completion of this dredging project is 2020.
The Lakers are shutting down two of their young stars for the remainder of the regular season as playoff hopes have faded and troubling medical realities have come to light.The Lakers learned Friday that Brandon Ingram, has a blood clot in his arm that will keep him out for the remainder of the season, the team announced Saturday morning. Multiple media reports have also suggested Lonzo Ball, who has been out since Jan. 19 with a Grade 3 ankle sprain, will not play for the rest of the season after it was determined he was not close to returning to the court.Of the two health updates, Ingram’s was more grimly received. The second overall pick in the 2016 NBA draft had missed the past two games due to a sore right shoulder, underwent further testing by the team’s medical staff Friday, which revealed a Deep Venous Thrombosis (DVT) in his right arm – a potentially serious medical condition if left untreated.The Lakers first reported that Ingram was feeling soreness Monday after morning shootatound. The issue caused the medical staff to hold him out against the Clippers and the Denver Nuggets this week. Coach Luke Walton told reporters Wednesday that Ingram was feeling pain when he lifted his right arm above his head. AD Quality Auto 360p 720p 1080p Top articles1/5READ MOREUCLA alum Kenny Clark signs four-year contract extension with PackersWalton declined to answer several questions about Ingram’s condition, including how he was taking the news.“I’m not getting into any of that about Brandon right now,” he said prior to the Lakers’ Saturday game against the Boston Celtics. “I’m just finding out a lot of it myself. All I’m going to say on him right now is that he’s out for the rest of the season.”The setback comes just as Ingram was hitting a career-best stride on the court, averaging 18.3 ppg, 5.1 rpg and 3 apg in his third professional season. While the Lakers have struggled for much of the past two months, Ingram rose above the difficult circumstances, averaging 24 points on 53.4 percent shooting and emerging as a legitimate complementary piece to LeBron James.The Lakers have not yet determined what treatment Ingram will undergo for his condition, and are still in the information-gathering stage. DVT is commonly treated with blood thinners, which would require a player to sit out.The decision to keep Ball out is one that the Lakers have been shifting toward lately: On Friday, Walton cast doubt that Ball might make a return for any of the 16 remaining games. While Walton didn’t officially confirm Ball would not play for the rest of the year, he suggested again Saturday that the second overall pick in the 2017 Draft wasn’t close to suiting up again. “From what I can tell — from my eye test, not being a doctor — he’s not doing basketball stuff yet,” he said. “So we’ll see.”“In their official stance, the Lakers said Ball’s ankle would be re-evaluated in two weeks and had been cleared for non-contact basketball activities. But Walton had suggested in the days leading up to the reports that the Lakers could reach a point that it would be more valuable to sit Ball to keep him healthy for the off-season.”Ball similarly was going through a strong stretch when he was injured, helping the Lakers, seemingly preparing to help the team turn a corner after a multitude of struggles without James, who was missing with a groin injury. Ball ended up with 9.9 ppg, 5.4 apg and 5.3 rpg in 47 games in his sophomore effort. He consistently drew praise as one of the Lakers’ best on-ball defenders: The Lakers’ defensive rating rose from 105.3 points per 100 possessions when he was on the court to 110 when he was off.The Lakers have been roiled by medical setbacks throughout the season, missing James, Ingram, Ball, Rajon Rondo, JaVale McGee and Tyson Chandler for long stretches. Kyle Kuzma also missed Saturday’s start, his second straight game since rolling his right ankle on Monday.Six-and-a-half games out in the playoff standings as of Saturday morning, the Lakers have embraced a policy of safeguarding their stars from overuse and injury with the postseason now out of reach. The team recently acknowledged it is monitoring James’ minutes and possibly could sit him out for the second game of back-to-backs.It’s not the first time this year Ingram has been sidelined – he missed four games at the beginning of the year for his role in a brawl with the Houston Rockets in the Lakers’ home opener. He later missed seven games with a sprained ankle in December.Ball’s injury was his first this year, but it’s the second season that Ball has finished with less than 55 games played. Newsroom GuidelinesNews TipsContact UsReport an Error